Abstract
The rapid development of molecular genetic technology in the past decade has opened up exciting new vistas for the application of this technology to the manufacture of important biological molecules, as well as to the diagnosis and treatment of inherited diseases. The enthusiasm attending this development in the research laboratories of universities and medical schools generated an equal stir in the corporate world, where the possibilities for commercial exploitation of these dramatic scientific advances were immediately appreciated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Aubrey Milunsky and George J. Annas
About this chapter
Cite this chapter
Relman, A.S. (1985). The Academic-Corporate Merger in Medicine. In: Milunsky, A., Annas, G.J. (eds) Genetics and the Law III. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4952-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4952-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4954-9
Online ISBN: 978-1-4684-4952-5
eBook Packages: Springer Book Archive